EMBO Molecular Medicine · 2018 · 174 citations · 41 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurodegenerationSignal TransductionAlzheimer DiseaseMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationProtein Aggregation DisordersAmyloid Beta PathwaysAmyloid Beta PeptidesAmyloid FibrilsAmyloid Plaque FormationBeta-sheet FibrilsNeurodegenerative Disease MechanismsTrem1 Signaling
Rare coding variants in the triggering receptor expressed on myeloid cells 2 (TREM2) are associated with increased risk for Alzheimer's disease (AD), but how they confer this risk remains uncertain. We assessed binding of TREM2, AD-associated TREM2 variants to various forms of Aβ and APOE in multiple assays. TREM2 interacts directly with various forms of Aβ, with highest affinity interactions observed between TREM2 and soluble Aβ42 oligomers. High-affinity binding of TREM2 to Aβ oligomers is characterized by very slow dissociation. Pre-incubation with Aβ is shown to block the interaction of APOE In cellular assays, AD-associated variants of TREM2 reduced the amount of Aβ42 internalized, and in NFAT assay, the R47H and R62H variants decreased NFAT signaling activity in response to Aβ42. These studies demonstrate i) a high-affinity interaction between TREM2 and Aβ oligomers that can block interaction with another TREM2 ligand and ii) that AD-associated TREM2 variants bind Aβ with equivalent affinity but show loss of function in terms of signaling and Aβ internalization.
41
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Yaming Wang, Marina Cella, Kaitlin Mallinson et al. · Cell · 2015 · 1.8K citations · Full text